AFT-63

Please Note:

The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.

Available Sites

• Missouri Baptist Medical Center

Contact Person(s)

• Jessie Laycock, 314-996-5391

View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.